Lixte Biotechnology Holdings, Inc. Share Price
LIXTLixte Biotechnology Holdings, Inc. Stock Performance
Open $3.07 | Prev. Close $2.90 | Circuit Range N/A |
Day Range $3.07 - $3.07 | Year Range $0.64 - $6.14 | Volume 127 |
Average Traded $3.07 |
Lixte Biotechnology Holdings, Inc. Share Price Chart
About Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.
Lixte Biotechnology Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Apr-26 | $2.89 | $2.90 | -1.36% |
06-Apr-26 | $2.99 | $2.94 | -2.97% |
02-Apr-26 | $3.03 | $3.03 | -6.19% |
01-Apr-26 | $3.23 | $3.23 | +4.19% |
31-Mar-26 | $3.03 | $3.10 | +0.98% |
30-Mar-26 | $3.07 | $3.07 | -0.65% |
27-Mar-26 | $2.93 | $3.09 | +4.57% |
FAQs on Lixte Biotechnology Holdings, Inc. Share Price
Can I buy Lixte Biotechnology Holdings, Inc. shares in India?
What is the share price of Lixte Biotechnology Holdings, Inc.?
What is the 5 year returns of Lixte Biotechnology Holdings, Inc.?
What are the high & low stock price of Lixte Biotechnology Holdings, Inc. today?
What is the 52-week high and low of Lixte Biotechnology Holdings, Inc. stock?